79 related articles for article (PubMed ID: 2600788)
1. Technetium-99m labeled p-aminohippuric acid analogues: renal function agents.
Zhang Z; Bhargava KK; Chun SB; Blaufox MD; Chervu LR
J Pharm Sci; 1989 Oct; 78(10):829-32. PubMed ID: 2600788
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication.
Chervu LR; Sundoro BM; Blaufox MD
J Nucl Med; 1984 Oct; 25(10):1111-5. PubMed ID: 6548256
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of p-aminohippuric acid analog and its labeling by technetium-99m.
Zmbova B; Djokić D; Bogdanova V; Tadzer I; Ajdinović B; Rastovac M
Int J Rad Appl Instrum A; 1989; 40(3):225-34. PubMed ID: 2541109
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the renal clearance of technetium-99m PAHIDA in dogs.
Summerville DA; Packard AB; Bartynski B; Lim KS; Chervu LR; Treves ST
J Nucl Med; 1987 May; 28(5):907-9. PubMed ID: 3553465
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the renal clearance of 99mTc-DTPA and inulin, 131I-hippurate and PAH and creatinine clearance in Wistar rats].
Hagemann J; Su LM; Strangfeld D; Schürer M; Siewert H; Pietsch R; Kruse I; Priem F
Radiobiol Radiother (Berl); 1988; 29(4):497-505. PubMed ID: 3055016
[No Abstract] [Full Text] [Related]
6. Cysteine, a chelating moiety for synthesis of technetium-99m radiopharmaceuticals--Part IV. Benzyl cysteine and derivatives.
Mukherjee S; Chatterjee J; Dobe P; Sengupta C; Banerjee S
Nucl Med Biol; 1993 May; 20(4):413-26. PubMed ID: 8504284
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of renal concentration of technetium-99m glucoheptonate.
Lee HB; Blaufox MD
J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
10. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biodistribution studies of two novel radiolabeled estrone derivatives.
Enginar H; Unak P; Lambrecht FY; Biber Muftuler FZ; Medine EI
In Vivo; 2008; 22(1):93-100. PubMed ID: 18396789
[TBL] [Abstract][Full Text] [Related]
12. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.
He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT
Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812
[TBL] [Abstract][Full Text] [Related]
13. A new, general synthetic route to multidentate N,S ligands for use in technetium-99m radiopharmaceuticals. Preparation of diamido disulfur, diamino dithiol, and tripodal N3S3 prototypes. Comparative biodistributions of [99mTcvO-DADS]- analogues which contain 5,5,5- and 5,7,5-membered chelate ring systems.
Stepniak-Biniakiewicz D; Chen BH; Deutsch E
J Med Chem; 1992 Jan; 35(2):274-9. PubMed ID: 1732543
[TBL] [Abstract][Full Text] [Related]
14. Technetium thiodiglycollic acid (99mTc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function.
Nowotnik DP; Pickett RD; Allen CD
Eur J Nucl Med; 1985; 11(8):285-9. PubMed ID: 4076236
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic derivatives of 99mTc(Sn)pyridoxylidenephenylalanine: a structure distribution relationship (SDR) study on technetium-99m complexes.
Kato-Azuma M
Int J Appl Radiat Isot; 1982 Oct; 33(10):937-44. PubMed ID: 7152710
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
17. Cationic technetium-99m complexes of N-substituted pyridoxal derivatives as renal function agents.
Karube Y; Iwamoto K; Takata J
J Nucl Med; 1994 Oct; 35(10):1691-7. PubMed ID: 7931673
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran.
McAfee JG; Subramanian G; Schneider RF; Roskopf M; Lyons B; Ritter C; Zapf-Longo C; Palladino E; Thomas FD
J Nucl Med; 1985 Apr; 26(4):375-84. PubMed ID: 3981257
[TBL] [Abstract][Full Text] [Related]
19. [Investigations on 131I-hippurate-clearance in obstructive-uropathy; extraction of para-aminohippuric acid and 131I-hippurate in the acutely obstructed canine kidney (author's transl)].
Doppelfeld E
Nuklearmedizin; 1979 Oct; 18(4):181-5. PubMed ID: 530845
[TBL] [Abstract][Full Text] [Related]
20. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
